Telomir Pharmaceuticals Statistics
Total Valuation
TELO has a market cap or net worth of $41.26 million. The enterprise value is $36.24 million.
Important Dates
The last earnings date was Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TELO has 34.38 million shares outstanding. The number of shares has increased by 9.22% in one year.
| Current Share Class | 34.38M |
| Shares Outstanding | 34.38M |
| Shares Change (YoY) | +9.22% |
| Shares Change (QoQ) | +2.65% |
| Owned by Insiders (%) | 14.83% |
| Owned by Institutions (%) | 6.53% |
| Float | 19.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.73 |
| P/TBV Ratio | 8.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.00, with a Debt / Equity ratio of 0.04.
| Current Ratio | 7.00 |
| Quick Ratio | 6.72 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7,768.74 |
Financial Efficiency
Return on equity (ROE) is -384.26% and return on invested capital (ROIC) is -230.32%.
| Return on Equity (ROE) | -384.26% |
| Return on Assets (ROA) | -186.93% |
| Return on Invested Capital (ROIC) | -230.32% |
| Return on Capital Employed (ROCE) | -189.28% |
| Weighted Average Cost of Capital (WACC) | 3.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.02M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.60% in the last 52 weeks. The beta is -0.21, so TELO's price volatility has been lower than the market average.
| Beta (5Y) | -0.21 |
| 52-Week Price Change | -51.60% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 37.24 |
| Average Volume (20 Days) | 229,296 |
Short Selling Information
The latest short interest is 1.02 million, so 2.98% of the outstanding shares have been sold short.
| Short Interest | 1.02M |
| Short Previous Month | 1.04M |
| Short % of Shares Out | 2.98% |
| Short % of Float | 5.38% |
| Short Ratio (days to cover) | 4.84 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.39M |
| Pretax Income | -9.22M |
| Net Income | -9.22M |
| EBITDA | n/a |
| EBIT | -9.39M |
| Earnings Per Share (EPS) | -$0.29 |
Full Income StatementBalance Sheet
The company has $5.56 million in cash and $202,869 in debt, with a net cash position of $5.36 million or $0.16 per share.
| Cash & Cash Equivalents | 5.56M |
| Total Debt | 202,869 |
| Net Cash | 5.36M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 4.96M |
| Book Value Per Share | 0.14 |
| Working Capital | 4.96M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.60M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 202,869 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
